TOP TIERMARKET NEWSWIRE
SEC Form 4 history

TEVA PHARMACEUTICAL ADR (TEVA) insider trades

TEVA PHARMACEUTICAL ADR (TEVA) insider trading activity (SEC Form 4). Over the trailing 90 days, TEVA insiders filed 0 purchases totalling $0 and 9 sales totalling $13.0M — net SELLING of $13.0M. Most recent filing: Aug 10, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
9
$13.0M
Net (90d)
-$13.0M
net selling
Most recent
Aug 10, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 10, 2026Zaks Tal ZviDirS Sale—$34.87$593filing
Aug 5, 2026Hughes Eric ASee "Remarks"S SaleOE—$34.88$892Kfiling
Aug 5, 2026Jover PlacidSee "Remarks"S SaleOE—$34.88$447Kfiling
Jun 22, 2026Shields MatthewEVP, Global OperationsS Sale—$32.19$322Kfiling
Jun 16, 2026Kalif Eliyahu SharonEVP, CFOS Sale—$34.10$3.6Mfiling
Jun 8, 2026Francis Richard DPres, CEOS SaleOE—$34.35$211Kfiling
Jun 4, 2026Shields MatthewEVP, Global OperationsS SaleOE—$32.87$532Kfiling
May 18, 2026Kalif Eliyahu SharonEVP, CFOS Sale—$35.61$5.5Mfiling
May 18, 2026Lippman EvanEVP, Business DevelopmentS SaleOE—$35.58$1.5Mfiling